Evoli, A., & Damato, V. (2023). Conventional and emerging treatments and controversies in myasthenia gravis. Expert Review of Neurotherapeutics, 23(8), 1–12. https://doi.org/10.1080/14737175.2023.2207739

Ojha, P. T., Gaikwad, A. M., Singh, R., Jagiasi, K., & Nagendra, S. (2023). The clinical outcome in AChR positive generalised myasthenia gravis: A retrospective observational study. Annals of Indian Academy of Neurology, 26(4), 395–400. https://doi.org/10.4103/aian.aian_11_23

Piehl, F., Eriksson-Dufva, A., Budzianowska, A., Feresiadou, A., Hansson, W., Hietala, M. A., ... & RINOMAX Study Group. (2022). Efficacy and safety of rituximab for new-onset generalized myasthenia gravis: The RINOMAX randomized clinical trial. JAMA Neurology, 79(11), 1105–1112. https://doi.org/10.1001/jamaneurol.2022.2887

Narayanaswami, P., Sanders, D. B., Wolfe, G., Benatar, M., Cea, G., Evoli, A., ... & International MG Consensus Core Committee. (2021). International consensus guidance for management of myasthenia gravis: 2020 update. Neurology, 96(3), 114–122. https://doi.org/10.1212/WNL.0000000000011224

Verschuuren, J. J., Palace, J., Murai, H., Tannemaat, M. R., Kaminski, H. J., & Bril, V. (2022). Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. The Lancet Neurology, 21(2), 189–202. https://doi.org/10.1016/S1474-4422(21)00463-1

Blalock, A., Mason, M. F., Morgan, H. J., & Riven, S. S. (1939). Myasthenia gravis and tumors of the thymic region: Report of a case in which the tumor was removed. Annals of Surgery, 110(4), 544–561. https://doi.org/10.1097/00000658-193910000-00005

Mi, W., Silvestri, N. J., & Wolfe, G. I. (2019). A neurologist's perspective on thymectomy for myasthenia gravis: Current perspective and future trials. Thoracic Surgery Clinics, 29(2), 143–150. https://doi.org/10.1016/j.thorsurg.2018.12.003

Stathopoulos, P., & Dalakas, M. C. (2022). Evolution of anti-B cell therapeutics in autoimmune neurological diseases. Neurotherapeutics, 19(3), 691–710. https://doi.org/10.1007/s13311-022-01216-5

Zografou, C., Vakrakou, A. G., & Stathopoulos, P. (2021). Short- and long-lived autoantibody-secreting cells in autoimmune neurological disorders. Frontiers in Immunology, 12, Article 686466. https://doi.org/10.3389/fimmu.2021.686466

Marino, M., Basile, U., Spagni, G., Napodano, C., Iorio, R., Gulli, F., ... & Bartoccioni, E. (2020). Long-lasting rituximab-induced reduction of specific-but not total-IgG4 in MuSK-positive myasthenia gravis. Frontiers in Immunology, 11, Article 613. https://doi.org/10.3389/fimmu.2020.00613

Nowak, R. J., Coffey, C. S., Goldstein, J. M., Dimachkie, M. M., Benatar, M., Kissel, J. T., ... & Barohn, R. J. (2021). Phase 2 trial of rituximab in acetylcholine receptor antibody-positive generalized myasthenia gravis: The BeatMG study. Neurology, 98(4), e376–e389. https://doi.org/10.1212/WNL.0000000000013121

Di Stefano, V., Lupica, A., Rispoli, M. G., Di Muzio, A., Brighina, F., & Rodolico, C. (2020). Rituximab in AChR subtype of myasthenia gravis: Systematic review. Journal of Neurology, Neurosurgery & Psychiatry, 91(4), 392–395. https://doi.org/10.1136/jnnp-2019-322606

Li, T., Zhang, G. Q., Li, Y., Dong, S. A., Wang, N., Yi, M., ... & Li, Z. L. (2021). Efficacy and safety of different dosages of rituximab for refractory generalized AChR myasthenia gravis: A meta-analysis. Journal of Clinical Neuroscience, 85, 6–12. https://doi.org/10.1016/j.jocn.2020.11.046

Brauner, S., Eriksson-Dufva, A., Hietala, M. A., Frisell, T., Press, R., & Piehl, F. (2020). Comparison between rituximab treatment for new-onset generalized myasthenia gravis and refractory generalized myasthenia gravis. JAMA Neurology, 77(8), 974–981. https://doi.org/10.1001/jamaneurol.2020.1637

Gronseth, G. S., & Barohn, R. J. (2000). Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55(1), 7–15. https://doi.org/10.1212/WNL.55.1.7

Wolfe, G. I., Kaminski, H. J., Aban, I. B., Minisman, G., Kuo, H. C., Marx, A., ... & MGTX Study Group. (2016). Randomized trial of thymectomy in myasthenia gravis. New England Journal of Medicine, 375(6), 511–522. https://doi.org/10.1056/NEJMoa1602489